Market Overview:
The global Humira biosimilar market is estimated to be valued at US$772.1 million in 2023 and is projected to grow at a CAGR of 25.9% during the forecast period of 2023-2030. Humira biosimilars are highly similar versions of the original Humira medication, which is used to treat several autoimmune diseases. These biosimilars offer advantages such as reduced costs and increased accessibility to patients, as they are more affordable alternatives to the original product. ... Read more
